The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypersensitivity reactions from taxol.
Weiss, R. B., Donehower, R. C., Wiernik, P. H., Ohnuma, T., Gralla, R. J., Trump, D. L., Baker, J. R., Van Echo, D. A., Von Hoff, D. D., & Leyland-Jones, B. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.7.1263 · Cited by 1,174
Paclitaxel and its formulations
Singla, A. K., Garg, A., & Aggarwal, D. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00986-3 · Cited by 1,100
Zhan, C., Gu, B., Xie, C., Li, J., Liu, Y., & Lu, W. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.12.020 · Cited by 366
Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels
Lee, H., Mok, H., Lee, S., Oh, Y.-K., & Park, T. G. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.02.011 · Cited by 365
Heo, D. N., Yang, D. H., Moon, H.-J., Lee, J. B., Bae, M. S., Lee, S. C., Lee, W. J., Sun, I.-C., & Kwon, I. K. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.064 · Cited by 357
Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with Paclitaxel
Danhier, F., Vroman, B., Lecouturier, N., Crokart, N., Pourcelle, V., Freichels, H., Jérôme, C., Marchand-Brynaert, J., Feron, O., & Préat, V. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.011 · Cited by 335
Nasti, A., Zaki, N. M., de Leonardis, P., Ungphaiboon, S., Sansongsak, P., Rimoli, M. G., & Tirelli, N. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9908-0 · Cited by 312
Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel
Liu, D., Liu, Z., Wang, L., Zhang, C., & Zhang, N. (2011) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.02.038 · Cited by 245
Self-citationNanostructured hyaluronic acid-based materials for active delivery to cancer
Ossipov, D. A. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425241003730399 · Cited by 191
Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors
Rivkin, I., Cohen, K., Koffler, J. Y., Melikhov, D., Peer, D., & Margalit, R. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.05.067 · Cited by 144
Park, K., Lee, M., Kim, K. S., & Hahn, S. K. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.03.018 · Cited by 133
Liu, D., Liu, F., Liu, Z., Wang, L., & Zhang, N. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200402e · Cited by 108
Self-citationKim, T. G., Lee, H., Jang, Y., & Park, T. G. (2009) · Biomacromolecules · doi:10.1021/bm900116r · Cited by 99
DNA/polyethyleneimine/hyaluronic acid small complex particles and tumor suppression in mice
Ito, T., Yoshihara, C., Hamada, K., & Koyama, Y. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.12.032 · Cited by 98
Xin, D., Wang, Y., & Xiang, J. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9997-9 · Cited by 95
Zhao, P., Wang, H., Yu, M., Cao, S., Zhang, F., Chang, J. K., & Niu, R. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0196-5 · Cited by 71
Jiang, X., Xin, H., Sha, X., Gu, J., Jiang, Y., Law, K., Chen, Y., Chen, L., Wang, X. D., & Fang, X. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.08.052 · Cited by 68
Study on docetaxel-loaded nanoparticles with high antitumor efficacy against malignant melanoma
Zheng, D., Li, X., Xu, H., Lu, X., Hu, Y., & Fan, W. (2009) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmp045 · Cited by 62
Journo-Gershfeld, G., Kapp, D., Shamay, Y., Kopeček, J., & David, A. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0672-1 · Cited by 59
Stefano, I. D., Battaglia, A., Zannoni, G. F., Prisco, M. G., Fattorossi, A., Travaglia, D., Baroni, S., Renier, D., Scambia, G., Ferlini, C., et al. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1462-2 · Cited by 59
Huang (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s10393 · Cited by 39
Hyperthermic Enhancement of the Apoptotic and Antiproliferative Activities of Paclitaxel
Othman, T., Goto, S., Lee, J.-B., Taimura, A., Matsumoto, T., & Kosaka, M. (2001) · Pharmacology · doi:10.1159/000056096 · Cited by 38
Cited by
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come
Yingchoncharoen, P., Kalinowski, D. S., & Richardson, D. R. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.012070 · Cited by 744
Hyaluronic acid for anticancer drug and nucleic acid delivery
Dosio, F., Arpicco, S., Stella, B., & Fattal, E. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.011 · Cited by 596
Gordillo-Galeano, A., & Mora-Huertas, C. E. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.10.017 · Cited by 569
Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles
Alavi, M., & Hamidi, M. (2019) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmpt-2018-0032 · Cited by 405
Hyaluronic acid-based biopharmaceutical delivery and tumor-targeted drug delivery system
Huang, G., & Huang, H. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.04.015 · Cited by 353
Metadata
- Authors
- Yang, X.-Y., Li, Y.-X., Li, M., Zhang, L., Feng, L.-X., & Zhang, N.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 334
- Issue
- 2
- Pages
- 338-345
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2059166844
- Cited by
- 262
- References
- 22
- FWCI
- 6.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.